Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $147.46 USD
Change Today -4.32 / -2.85%
Volume 5.5M
AMGN On Other Exchanges
Hong Kong
Sao Paulo
As of 8:10 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Roger M. Perlmutter M.D., Ph.D.

AgeTotal Calculated CompensationThis person is connected to 34 board members in 1 different organizations across 8 different industries.

See Board Relationships


Dr. Roger M. Perlmutter, M.D., Ph.D. has been Executive Vice President and President of Merck Research Laboratories at Merck & Co. Inc. since April 15, 2013. Dr. Perlmutter serves as Science Partner at The Column Group LLC. Dr. Perlmutter was a Professor in the Departments of Immunology, Biochemistry and Medicine at the University of Washington in Seattle from January 1991 to January 1997. From 1981 to 1984, he was a Lecturer in the Division of Biology at the California ...

Read Full Background

Corporate Headquarters*

One Amgen Center Drive
Thousand Oaks, California 91320-1799

United States

Phone: 805-447-1000
Fax: 805-447-1010

Board Members Memberships*



PhD 1979
Washington University, St. Louis
MD 1979
Washington University, St. Louis
Unknown/Other Education 1973
Reed College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,500,000

Stock Options*

Restricted Stock Awards$3,538,245
All Other Compensation$91,663
Exercisable Options75,147
Exercisable Options Value$887,486
Unexercisable Options342,868
Unexercisable Options Value$1,774,996
Total Value of Options$2,662,481
Total Number of Options418,015

Total Compensation*

Total Annual Cash Compensation$3,363,538
Total Short Term Compensation$1,500,000
Other Long Term Compensation$3,629,908
Total Calculated Compensation$8,243,454
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMGN:US $147.46 USD -4.32


Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
Jean-Paul Agon Chairman, Chief Executive Officer and Chairman of Strategy & Sustainable Development Committee
L'Oreal SA
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at